Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Prions are affected by evolution at two levels.

Wickner RB, Kelly AC.

Cell Mol Life Sci. 2016 Mar;73(6):1131-44. doi: 10.1007/s00018-015-2109-6. Epub 2015 Dec 28. Review.

PMID:
26713322
2.

Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.

Kim DH, Lee HM, Ryou C.

J Korean Med Sci. 2014 Dec;29(12):1604-9. doi: 10.3346/jkms.2014.29.12.1604. Epub 2014 Nov 21.

3.

Ascertainment bias causes false signal of anticipation in genetic prion disease.

Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G, Karch A, Kenny J, Collinge J, Takada LT, Forner S, Fong JC, Mead S, Geschwind MD.

Am J Hum Genet. 2014 Oct 2;95(4):371-82. doi: 10.1016/j.ajhg.2014.09.003.

4.

Neuroepidemiology and the epidemiology of viral infections of the nervous system.

Sejvar J.

Handb Clin Neurol. 2014;123:67-87. doi: 10.1016/B978-0-444-53488-0.00003-1. Review.

5.

Sporadic fatal insomnia in an adolescent.

Blase JL, Cracco L, Schonberger LB, Maddox RA, Cohen Y, Cali I, Belay ED.

Pediatrics. 2014 Mar;133(3):e766-70. doi: 10.1542/peds.2013-1396. Epub 2014 Feb 2.

6.
7.

An overview of human prion diseases.

Imran M, Mahmood S.

Virol J. 2011 Dec 24;8:559. doi: 10.1186/1743-422X-8-559. Review.

8.

Detection of four novel polymorphisms in PrP gene of Pakistani sheep (Damani and Hashtnagri) and goats (Kamori and Local Hairy) breeds.

Hussain A, Babar ME, Imran M, Haq IU, Javed MM.

Virol J. 2011 May 20;8:246. doi: 10.1186/1743-422X-8-246.

9.

The design and application of fluorophore-gold nanoparticle activatable probes.

Swierczewska M, Lee S, Chen X.

Phys Chem Chem Phys. 2011 Jun 7;13(21):9929-41. doi: 10.1039/c0cp02967j. Epub 2011 Mar 7. Review.

10.

Normal modes of prion proteins: from native to infectious particle.

Samson AO, Levitt M.

Biochemistry. 2011 Mar 29;50(12):2243-8. doi: 10.1021/bi1010514. Epub 2011 Mar 4.

11.

Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

Krasemann S, Neumann M, Geissen M, Bodemer W, Kaup FJ, Schulz-Schaeffer W, Morel N, Aguzzi A, Glatzel M.

PLoS One. 2010 Nov 11;5(11):e13906. doi: 10.1371/journal.pone.0013906.

12.

Gaucher disease and parkinsonism, a molecular link theory.

Goldin E.

Mol Genet Metab. 2010 Dec;101(4):307-10. doi: 10.1016/j.ymgme.2010.08.004. Epub 2010 Aug 10.

13.

Human prion diseases in the United States.

Holman RC, Belay ED, Christensen KY, Maddox RA, Minino AM, Folkema AM, Haberling DL, Hammett TA, Kochanek KD, Sejvar JJ, Schonberger LB.

PLoS One. 2010 Jan 1;5(1):e8521. doi: 10.1371/journal.pone.0008521.

14.

Chronic wasting disease and potential transmission to humans.

Belay ED, Maddox RA, Williams ES, Miller MW, Gambetti P, Schonberger LB.

Emerg Infect Dis. 2004 Jun;10(6):977-84. Review.

15.

Presenile dementia syndromes: an update on taxonomy and diagnosis.

Greicius MD, Geschwind MD, Miller BL.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):691-700. Review.

Items per page

Supplemental Content

Write to the Help Desk